Haifa, Israel, October 22, 2009 --(PR.com
)-- NumberCrunch LTD today announced the conclusion of the testing phase for NumberCrunch LTD's AUC1 advanced artificial intelligence algorithm in Hologic, Inc. (NASDAQ: HOLX) ImageChecker CAD (computer aided detection) mammography system. The patent-pending AUC1 algorithm, which has been optimized for use in Hologic's ImageChecker software, demonstrated a 15.8% improvement in performance.
"We chose to approach Hologic for testing our algorithm because of their reputation for excellence in CAD research and development. We are very happy with the testing and with the results and hope to bring the technology soon to physicians across the country by partnering with other CAD providers" said Avi Marcus, founder and CTO of NumberCrunch LTD.
About NumberCrunch LTD
NumberCrunch LTD is an Israeli company specializing in commercial applications of advanced artificial intelligence algorithms such as its patent-pending AUC1 algorithm. Its proprietary IP has the capability to significantly improve the predictive power of machine learning applications and aid companies' efforts in a wide variety of fields from computer-aided-diagnosis, computer-aided-drug-design, voice recognition and more.